Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grazia Aleppo

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
Diabetes Care|March 29, 2022
Response to Comment on Aleppo et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737Ryan Bailey, Peter Calhoun, Roy W Beck, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|May 19, 2025
Safety of a Novel Continuous Glucose Monitoring-Informed Insulin Bolus Calculator Mobile Application for People With Type 1 or Type 2 DiabetesMansur Shomali, Colleen Kelly, Abhimanyu Kumbara, et al.
Frontiers in Endocrinology|October 1, 2024
The critical elements of digital health in diabetes and cardiometabolic careMansur Shomali, Pablo Mora, Grazia Aleppo, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 9, 2024
Switching to Tirzepatide 5 mg From Glucagon-Like Peptide-1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of TreatmentSerge Jabbour, Jim S Paik, Grazia Aleppo, et al.
Journal of Diabetes and Its Complications|October 10, 2017
Reported gastroparesis in adults with type 1 diabetes (T1D) from the T1D Exchange clinic registryGrazia Aleppo, Peter Calhoun, Nicole C Foster, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 1, 2022
Expert Roundtable on Continuous Glucose MonitoringCheryl Rosenfeld, Thomas Blevins, Grazia Aleppo, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 4, 2024
The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative ReviewJanet B McGill, Irl B Hirsch, Christopher G Parkin, et al.
BMJ Open Quality|June 5, 2018
Risk assessment of the hospital discharge process of high-risk patients with diabetesTeresa A Pollack, Vidhya Illuri, Rebeca Khorzad, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 10, 2023
Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management SystemGrazia Aleppo, Daniel J DeSalvo, Felipe Lauand, et al.
Diabetes Technology & Therapeutics|April 2, 2025
Reduction of Postprandial Glucose Excursions in Adults, Adolescents, and Children with Type 1 Diabetes Using Ultra-Rapid Lispro Insulin and Control-IQ+ TechnologyGrazia Aleppo, Peter Calhoun, Ryan Bailey, et al.
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
Diabetes Care|March 29, 2022
Response to Comment on Aleppo et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737Ryan Bailey, Peter Calhoun, Roy W Beck, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|May 19, 2025
Safety of a Novel Continuous Glucose Monitoring-Informed Insulin Bolus Calculator Mobile Application for People With Type 1 or Type 2 DiabetesMansur Shomali, Colleen Kelly, Abhimanyu Kumbara, et al.
Frontiers in Endocrinology|October 1, 2024
The critical elements of digital health in diabetes and cardiometabolic careMansur Shomali, Pablo Mora, Grazia Aleppo, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 9, 2024
Switching to Tirzepatide 5 mg From Glucagon-Like Peptide-1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of TreatmentSerge Jabbour, Jim S Paik, Grazia Aleppo, et al.
Journal of Diabetes and Its Complications|October 10, 2017
Reported gastroparesis in adults with type 1 diabetes (T1D) from the T1D Exchange clinic registryGrazia Aleppo, Peter Calhoun, Nicole C Foster, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 1, 2022
Expert Roundtable on Continuous Glucose MonitoringCheryl Rosenfeld, Thomas Blevins, Grazia Aleppo, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 4, 2024
The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative ReviewJanet B McGill, Irl B Hirsch, Christopher G Parkin, et al.
BMJ Open Quality|June 5, 2018
Risk assessment of the hospital discharge process of high-risk patients with diabetesTeresa A Pollack, Vidhya Illuri, Rebeca Khorzad, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 10, 2023
Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management SystemGrazia Aleppo, Daniel J DeSalvo, Felipe Lauand, et al.
Diabetes Technology & Therapeutics|April 2, 2025
Reduction of Postprandial Glucose Excursions in Adults, Adolescents, and Children with Type 1 Diabetes Using Ultra-Rapid Lispro Insulin and Control-IQ+ TechnologyGrazia Aleppo, Peter Calhoun, Ryan Bailey, et al.
Pageof 13